Could a seizure drug ease pain for chronic pancreatitis patients on opioids?

NCT ID NCT05603702

First seen Mar 18, 2026 · Last updated Jun 13, 2026 · Updated 14 times

Summary

This early-phase study tests whether adding lacosamide, a seizure medication, to opioid therapy is safe and tolerable for people with chronic pancreatitis and ongoing abdominal pain. The goal is to reduce a condition called opioid-induced hyperalgesia, where opioids actually make pain worse. About 21 adults who are already on stable opioid treatment will take lacosamide for 7 days and be monitored for side effects and pain changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Indiana University

    Indianapolis, Indiana, 46202, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Ohio State University

    Columbus, Ohio, 43210, United States

  • Stanford University

    Stanford, California, 94305, United States

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, 15213, United States

Conditions

Explore the condition pages connected to this study.